Gts Securities LLC Catalent, Inc. Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $557,232 - $593,008	-10,400 Reduced 46.64%	11,900 $669,000
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $106,400 - $149,550	-2,500 Reduced 10.08%	22,300 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $366,852 - $530,898	11,400 Added 85.07%	24,800 $1.11 Million
Q3 2023 Nov 15, 2023	BUY	$44.2 - $50.2 $592,280 - $672,680	13,400 New	13,400 $610,000

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.